Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like Pharma Giant Bristol-Myers Squibb Plans Layoffs, Effective Oct. 6 August 9, 2017 IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017 Former Google Exec Steps Down as GRAIL CEO August 2, 2017
IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017